Cristina Crespo

University of Cambridge

Research Scholar

Trinity Ln

Cambridge, CB2 1TN

United Kingdom

SCHOLARLY PAPERS

6

DOWNLOADS

136

SSRN CITATIONS

3

CROSSREF CITATIONS

3

Scholarly Papers (6)

1.

Myriad's Impact on Gene Patents

Nature Biotechnology, Vol. 34, No. 11, p. 1119-1123, Nov. 2016, University of Cambridge Faculty of Law Research Paper No. 58/2017
Number of pages: 8 Posted: 04 Aug 2017 Last Revised: 25 Jun 2019
LML, University of Cambridge, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge
Downloads 70 (368,684)
Citation 1

Abstract:

Loading...

Patents, BRCA, Myriad, Gene Patents, Patent Publications, Empirical Analysis

2.

After Myriad, What Types of Claim Amendments Change a Patent Ineligible Isolated Gene Claim Into an Eligible Patent Claim That Is ‘Markedly Different’ From Nature?

35 Nature Biotechnology 820-825
Number of pages: 31 Posted: 22 May 2018
LML, University of Cambridge, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge
Downloads 39 (479,050)
Citation 1

Abstract:

Loading...

Patents, Patent Law, Biotechnology, Myriad, Gene Patents, US, Empirical Legal Research

3.

Was the Myriad Decision a ‘Surgical Strike’ on Isolated DNA Patents, or Does it Have Wider Impacts?

36(12) Nature Biotechnology 1146
Number of pages: 6 Posted: 27 Jun 2019 Last Revised: 18 Sep 2019
LML, University of Cambridge, University of Cambridge, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law
Downloads 27 (539,384)
Citation 1

Abstract:

Loading...

patents, gene patents, Myriad, wider impacts, DNA, markedly different, naturally occurring compounds, empirical, Biotechnology, US

4.

Mayo’s Impact on Patent Applications Related to Biotechnology, Diagnostics and Personalized Medicine

Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine. / Aboy, Mateo; Crespo, Cristina; Liddell, Kathleen; Minssen, Timo; Liddicoat, Johnathan, Nature Biotechnology, Vol. 37, 05.2019, p. 513-518.
Posted: 18 Aug 2020
LML, University of Cambridge, University of Cambridge, University of Cambridge - Faculty of Law, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and University of Cambridge - Faculty of Law

Abstract:

Loading...

5.

One Year After Vanda, Are Diagnostics Patents Transforming Into Methods of Treatment to Overcome Mayo-Based Rejections?

One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections? / Aboy, Mateo; Crespo, Cristina; Liddell, Kathleen ; Davey, Neal; Liddicoat, Johnathan; Minssen, Timo., Nature Biotechnology, Vol. 38, 09.03.2020, p. 279–283.
Posted: 18 Aug 2020
LML, University of Cambridge, University of Cambridge, University of Cambridge - Faculty of Law, affiliation not provided to SSRN, University of Cambridge - Faculty of Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

6.

How Does Emerging Patent Case Law in the US and Europe Affect Precision Medicine? How Will Today’s Patent Law Affect Tomorrow’s Innovation in the Areas of Biomarkers and Nature-Based Products; Diagnostics; and Algorithms, Big Data and AI?

Aboy, M., Liddell, K., Crespo, C. et al. How does emerging patent case law in the US and Europe affect precision medicine?. Nat Biotechnol 37, 1118–1125 (2019)
Posted: 18 Aug 2020
LML, University of Cambridge, Harvard Law School, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law, University of Cambridge, Harvard University - Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...